Topical cannabis extract for eczema itch
Treatments studied
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a cannabis-based cream on eczema-related itch over 4 weeks. It may help reduce itching if other treatments haven't worked, but requires pausing other skin products during the trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 25 years or older.
- You have eczema (including atopic dermatitis, nummular eczema, lichen simplex chronicus, or prurigo nodularis) with itching that has lasted more than 6 weeks.
- You are willing to stop using all other skin creams and ointments for the 4-week study period.
- You have not used oral steroids, immune-suppressing drugs, or light therapy in the past 3 months.
- You do not have serious health conditions like kidney disease, liver cirrhosis, cancer, thyroid disease, or unstable heart or lung disease.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acupuncture can help people with moderate-to-severe atopic dermatitis (eczema) feel less itchy. If you have persistent itch and are between 18 and 75 years old, you may qualify.
This trial compares two moisturizers for people with eczema (moderate rash) and healthy volunteers. It looks at how well they work and how the skin tolerates them after using a steroid cream.
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
This study tests whether roflumilast cream (a new anti-inflammatory medication applied to the skin) can reduce the intense itching caused by atopic dermatitis (eczema). You'll track your itching daily using a smartphone app and visit the clinic to see if the cream helps over time.
This trial tests a new injectable medicine called FB825 for people with moderate to severe eczema that hasn't improved enough with standard creams. The study aims to see if FB825 can reduce itching and skin symptoms safely.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
Hear when a new Eczema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.